Healthcare & Pharma

Commission Implementing Decision (EU) 2025/357 of 21 February 2025 not approving 5-chloro-2-methyl-2H-isothiazol-3-one (CIT) as an active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

  • Post author:
  • Post category:

COMMISSION IMPLEMENTING REGUL ATION (EU) 2024/2563 of 24 September 2024amending Implementing Regulation (EU) 2022/1646 as regards additional content of the national risk-based control plans and the national randomised sur veillance…

Continue ReadingCommission Implementing Decision (EU) 2025/357 of 21 February 2025 not approving 5-chloro-2-methyl-2H-isothiazol-3-one (CIT) as an active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

COMMISSION IMPLEMENTING DECISION (EU) postponing the expiry date of the approval of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

  • Post author:
  • Post category:

No Document Available

Continue ReadingCOMMISSION IMPLEMENTING DECISION (EU) postponing the expiry date of the approval of spinosad for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Legislation on Specific Assisted Reproductive Medicine

  • Post author:
  • Post category:

議案名「特定生殖補助医療に関する法律案」の審議経過情報項目内容議案種類参法議案提出回次217議案番号1議案件名特定生殖補助医療に関する法律案議案提出者秋野　公造君外三名衆議院予備審査議案受理年月日令和 7年 2月 7日衆議院予備付託年月日／衆議院予備付託委員会／衆議院議案受理年月日衆議院付託年月日／衆議院付託委員会／衆議院審査終了年月日／衆議院審査結果／衆議院審議終了年月日／衆議院審議結果／衆議院審議時会派態度衆議院審議時賛成会派衆議院審議時反対会派参議院予備審査議案受理年月日参議院予備付託年月日／参議院予備付託委員会／参議院議案受理年月日令和 7年 2月 5日参議院付託年月日／参議院付託委員会／参議院審査終了年月日／参議院審査結果／参議院審議終了年月日／参議院審議結果／公布年月日／法律番号／

Continue ReadingLegislation on Specific Assisted Reproductive Medicine